Annuloplasty System Market on Track for Strong Growth, Estimated to Grow at 6.9% CAGR Through 2029

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Annuloplasty System Market Through 2025?
The market size for the annuloplasty system has seen robust growth in the past few years. It is projected to rise from $0.65 billion in 2024 to $0.7 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 6.5%. The growth experienced in the historic period can be associated with an ageing population, an amplified occurrence of valvular heart diseases, an escalating acceptance of minimally invasive surgery, an increase in healthcare spending, and the development of cardiovascular specialty centers.

What's the Projected Size of the Global Annuloplasty System Market by 2029?
The market size for the annuloplasty system is anticipated to experience considerable growth over the next few years, expanding to an estimated $0.91 billion by 2029 with a 6.9% compound annual growth rate (CAGR). Various factors contribute to this expected growth during the forecast period, such as the widespread adoption of less invasive procedures, an increase in transcatheter annuloplasty operations, a mounting global incidence of cardiovascular disorders, an escalating demand for individualized medicine, and an expanding research landscape in the field of biomaterials. Key trends projected in this time-frame encompass the incorporation of artificial intelligence in surgical planning, the arrival of bioabsorbable annuloplasty rings, a surge in robot-assisted heart valve repairs, the escalating utilization of three-dimensional (3D) printing for tailored implants, and an increased emphasis on outpatient cardiac procedures.

View the full report here:
https://www.thebusinessresearchcompany.com/report/annuloplasty-system-global-market-report

Top Growth Drivers in the Annuloplasty System Industry: What's Accelerating the Market?
The escalating occurrence of cardiovascular ailments is anticipated to trigger the expansion of the annuloplasty system industry in the future. Cardiovascular diseases are a range of disorders affecting the heart and blood vessels, including conditions like coronary heart disease, heart failure, stroke, and hypertension. The rise in the incidence of these diseases greatly owes to an aging demographic, given the correlation between heart conditions and age-induced wear and tear of the heart and blood vessels. With the ability to effectively repair heart valves, restore optimal valve function, and enhance blood flow, annuloplasty systems play a crucial role in treating cardiovascular diseases. These systems improve patient outcomes by presenting minimally invasive alternatives for valve restoration, thereby cutting down on the recovery period and surgical risks. For example, in December 2023, doctor-certified deaths in Australia caused by coronary heart disease (CHD) saw a surge from 14,100 in 2021 to 14,900 in 2022, as reported by the Australian Institute of Health and Welfare, a government agency based in Australia. Hence, the growing prevalence of cardiovascular diseases is fuelling the expansion of the annuloplasty system market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24143&type=smp

What Long-Term Trends Will Define the Future of the Annuloplasty System Market?
Major corporations involved in the annuloplasty system market are concentrating on the creation of innovative items, such as advanced surgical valves and appliances, in order to improve the process efficiency and patient outcomes in the long run. The term "next-generation surgical valves and devices" refers to state-of-the-art medical equipment devised to streamline implantation and diminish surgical complication while augmenting the accuracy and longevity of valve repairs or replacements. For example, in June 2024, the Avalus Ultra valve, a new surgical aortic tissue valve was launched by Medtronic plc, a medical technology firm based in the US. The innovative low-profile valve holder and PEEK base frame of this device simplifies implantation, enhances surgical ease, and improves its performance over the long term. It also improves blood flow dynamics, while offering clear visibility for future valve-in-valve procedures.

What Are the Main Segments in the Annuloplasty System Market?
The annuloplasty system market covered in this report is segmented -

1) By Device Type: Annular Rings And Bands, Suture Annuloplasty Devices
2) By Procedure Type: Open Heart Surgery, Minimally Invasive Annuloplasty, Robotic Assisted Annuloplasty
3) By Valve Type: Mitral Valve, Tricuspid Valves, Aortic Valves, Pulmonary Valves
4) By End User: Hospitals, Ambulatory Surgical Centers, Cardiac Care Centers

Subsegments:
1) By Annular Rings And Bands: Rigid Annuloplasty Rings, Semi-Rigid Annuloplasty Rings, Flexible Annuloplasty Rings, Complete Annuloplasty Rings, Incomplete Annuloplasty Rings
2) By Suture Annuloplasty Devices: Adjustable Suture Annuloplasty Devices, Non-Adjustable Suture Annuloplasty Devices, Transcatheter Suture Annuloplasty Systems, Robotic-Assisted Suture Annuloplasty Devices

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=24143&type=smp

Which Top Companies are Driving Growth in the Annuloplasty System Market?
Major companies operating in the annuloplasty system market are Abbott Laboratories, Medtronic PLC, Becton Dickinson and Company, Boston Scientific Corporation, B. Braun Mesungen AG, Terumo Corporation, Edwards Lifesciences Corporation, LivaNova PLC, MicroPort Scientific Corporation, B.Braile Biomedica, Affluent Medical, Micro Interventional Devices Inc., NeoChord Inc., Labcor Laboratories Ltd., BioVentrix Inc., CryoLife Inc., Genesse BioMedical, BioStable Science & Engineering Inc., FOC Medical S.A, Cardiac Implants LLC.

Which Regions Will Dominate the Annuloplasty System Market Through 2029?
North America was the largest region in the annuloplasty system market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the annuloplasty system market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24143

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.